Sequence-specific cleavage of Huntingtin mRNA by catalytic DNA

Annals of Neurology

Volumn 46, Issue 3, 1999, Pages 366-373

  Yen, Laising ^a,b   Strittmatter, Stephen M ^a   Kalb, Robert G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUNTINGTIN; MESSENGER RNA;

ARTICLE; DNA SEQUENCE; ENZYME ACTIVITY; HUMAN; HUNTINGTON CHOREA; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRINUCLEOTIDE REPEAT;

DNA, CATALYTIC; DNA, SINGLE-STRANDED; EXONS; HUMANS; HUNTINGTON DISEASE; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; TRINUCLEOTIDE REPEATS;

EID: 0032832305     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199909)46:3<366::AID-ANA12>3.0.CO;2-D     Document Type: Article

References (27)

1. Martin JB, Gusella JF. Huntington's disease: pathogenesis and management. N Engl J Med 1986;315:1267-1276
2. Vonsattel JP, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-577
3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72: 971-983
4. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993;4:398-403
5. Davies SW, Turmaine M, Cozenx BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 1997;90: 537-548
6. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993
7. Klement IA, Skinner PJ, Kaytor MD, et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998;95:41-53
8. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998; 95:55-66
9. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87:493-506
10. Reddy PH, Williams M, Charles V, et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. Nat Genet 1998;20: 198-202
11. Duyao MP, Auerbach AB, Ryan A, et al. Inactivation of the mouse Huntington's disease gene homolog Hdh. Science 1995; 269:407-410
12. Zeitlin S, Liu JP, Chapman DL, et al. Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 1995;11:155-163
13. Santoro SW, Joyce GF. A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci USA 1997;94:4262-4266
14. Wagner RW. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994;372:333-335
15. Santoro SW, Joyce GF. Mechanism and utility of an RNA-cleaving DNA enzyme. Biochemistry 1998;37:13330-13342
16. Zuker M. On finding all suboptimal folding of an RNA molecule. Science 1989;244:48-52
17. Sugimoto N, Nakano S, Katoh M, et al. Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. Biochemistry 1995;34:11211-11216
18. Krol A, Carbot P. A guide for probing native small nuclear RNA and ribonucleoprotein structures. Methods Enzymol 1989;180:212-227
19. Sharp AH, Loev SJ, Schilling G, et al. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 1995;14:1065-1074
20. Denman RB. Using RNAFOLD to predict the activity of small catalytic RNAs. Biotechniques 1993;15:1090-1095
21. Gusella JF, Persichetti F, MacDonald ME. The genetic defect causing Huntington's disease: repeated in other contexts? Mol Med 1997;3:238-246
22. Ross CA. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 1997;19:1147-1150
23. Nasir J, Floresco SB, O'Kusky JR, et al. Targeted disruption ofthe Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 1995;81:811-823
24. White JK, Auerbach W, Duyao MP, et al. Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion. Nat Genet 1997;17:404-410
25. Ambrose CM, Duyao MP, Barnes G, et al. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 1994;20:27-38
26. Andrade MA, Bork P. HEAT repeats in the Huntington's disease protein. Nat Genet 1995;11:115-116
27. Matteucci MD, Wagner RW. In pursuit of antisense. Nature 1996;384:20-22